Scolaris Content Display Scolaris Content Display

Oral polio vaccine plus inactivated polio vaccine versus oral polio vaccine alone for reducing polio in children under two years of age

This is not the most recent version

References

Additional references

CDC 2001

Centers for Disease Control. Apparent global interruption of wild poliovirus type 2 transmission. MMWR 2001;50(12):222‐4.

CDC 2012

Centers for Disease Control. Chapter 17: Poliomyelitis. Epidemiology and Prevention of Vaccine‐Preventable Diseases. The Pink Book: Course Textbook. 12th Edition. Washington, DC: Centers for Disease Contol, 2012:249‐61.

Egger 1997

Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.

Ehrenfeld 2008

Ehrenfeld E, Glass RI, Agol VI, Chumakov K, Dowdle W, John TJ, et al. Immunisation against poliomyelitis: moving forward. Lancet 2008;371(9621):1385‐7.

Ghendon 1994

Ghendon Y, Robertson SE. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bulletin of the World Health Organization 1994;72(6):973‐83.

GPEI 2013

Global Polio Eradication Initiative. Inactivated polio vaccine (IPV). www.polioeradication.org/Polioandprevention/Thevaccines/Inactivatedpoliovaccine(IPV).aspx (accessed 18 July 2013).

Herremans 1999

Herremans TM, Reimerink JHJ, Buisman AM, Kimman TG, Koopmans MPG. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. Journal of Immunology 1999;162(8):5011‐8.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Krieg 2004

Krieg C, Maier R, Meyerhans A. Gut‐homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre‐immunized donors. Journal of General Virology 2004;85(6):1571‐9.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. The Cochrane Collaboration, Available from www.cochrane‐handbook.org.

Ogra 1968

Ogra PL, Karzon DT, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. New England Journal of Medicine 1968;279(17):893‐900.

Review Manager 2013 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.

Sabin 1959

Sabin AB. Present position of immunization against poliomyelitis with live virus vaccines. BMJ 1959;1(5123):663‐80.

Sutter 2010

Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double‐blind, controlled trial. Lancet 2010;376(9753):1682‐8.

Valtanen 2000

Valtanen S, Roivainen M, Piirainen L, Stenvik M, Hovi T. Poliovirus‐specific intestinal antibody responses coincide with decline of poliovirus excretion. Journal of Infectious Diseases 2000;182(1):1‐5.

WHO 1997

World Health Organization. Field guide for supplementary activities aimed at achieving polio eradication, 1996 revision. www.who.int/immunization_monitoring/resources/Field_guide_polio_96.pdf (accessed 26 November 2013).

WHO 2006

World Health Organization. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation. Weekly Epidemiological Record 2006;81(15):137‐44.

WHO 2010

World Health Organisation. Polio vaccines and polio immunization in the pre‐eradication era: WHO position paper. Weekly Epidemiological Record2010; Vol. 85, issue 23:213‐28.

WHO 2012

World Health Organisation. Poliomyelitis. www.who.int/mediacentre/factsheets/fs114/en/index.html (accessed 22 July 2013).